Clinical Trial Update: Magnesium Sulphate and Rocuronium in Patients Over 60 [Phase 1]

View source ↗

Summary

Phase 1 trial results evaluate the interaction and safety of magnesium sulfate with rocuronium in patients over 60 with head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)
• Rocuronium (rocuronium bromide)

Snippet

Sponsor: Pedro Rotava | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED